Patheon to Feature its Complex Formulation Technologies Expertise at the Upcoming CPhI – P-MEC –ICSE – BioPh – Pharmatec – Medtec Japan – Conference

Patheon personnel will be available to meet at the CPhI/ICSE Japan conference in Tokyo from April 24-26, 2013 to discuss how Patheon can actively support pharmaceutical and biotech companies achieve their key development and manufacturing goals.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

(PRWEB) April 14, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, will feature its wide range of complex formulation technologies for small molecules and biologics at the upcoming CPhI/ICSE conference in Tokyo, Japan.    

Dr. Kenji Yamada, Patheon, Advisor, will present “The Introduction of the Services of SoluPath™ and Quick to Clinic™” at 2:30 p.m. Japan Standard Time on April 26, 2013. SoluPath™ is an innovative and cost-effective service used to identify an optimal drug delivery system for compounds with poor bioavailability. In a recent case study, SoluPath™ improved bioavailability by four times in just three months. The Quick to Clinic™ program offers an accelerated delivery of Phase I clinical trial materials, guaranteeing finished product within four months of receipt of API.    

Patheon personnel will be at the upcoming CPhI/ICSE conference in Tokyo, Japan from April 24-26, 2013 and available to discuss how the company can actively support pharmaceutical and biotech companies achieve their objectives for both product development and manufacturing. The company will be exhibiting at Booth J-04 through the duration of the conference. To schedule a meeting in advance send an email to events(at)patheon(dot)com.

For more information on upcoming events, visit http://www.patheon.com/Knowledge-Library/Events.aspx.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 18 locations, including 14 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.